Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Primary Pulmonary Hypertension: later-stage trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Primary Pulmonary Hypertension: 1 US clinical trial tracked, none currently recruiting.

Primary Pulmonary Hypertension is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Liquidia Technologies, running 1 of these trials.

Enrollment posture brief

Registry condition primary-pulmonary-hypertension

OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Primary Pulmonary Hypert (th…0%
Open-enrollment share among volume-matched conditions near Primary Pulmonary Hypertension

Primary Pulmonary Hypertension has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Primary Pulmonary Hypertension on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Primary Pulmonary Hypertension is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

Named interventions

Most-linked intervention names on Primary Pulmonary Hypertension records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

LIQ861 Inhaled Treprostinil Drug
1 trials

US sites by state

Facility locations filed on Primary Pulmonary Hypertension trials. A trial with sites in several states counts in each.

Pennsylvania 1 trials
Oregon 1 trials
Ohio 1 trials
New Mexico 1 trials
Minnesota 1 trials
Massachusetts 1 trials
Louisiana 1 trials
Kansas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Primary Pulmonary Hypertension page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Primary Pulmonary Hypertension trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Liquidia Technologies sponsors the most Primary Pulmonary Hypertension trials on record, review their full trial history before evaluating a specific study. See Liquidia Technologies's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Primary Pulmonary Hypertension condition card totals 1 registered trials; most-linked intervention LIQ861 Inhaled Treprostinil; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.